Thursday, November 26, 2009
Still Enjoying Those Acquisitions, Pfizer? (The Motley Fool)
Tuesday, November 24, 2009
UPDATE:Judge Dismisses Second Bellwether Case Involving Fosamax (Nasdaq)
(Updates with Merck comment.) NEW YORK -(Dow Jones)- A federal judge has dismissed the second of three so- called "bellwether" cases over Merck & Co.'s (MRK) osteoporosis drug Fosamax.
Sunday, November 22, 2009
Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; Outlook Stable (Business Wire via Yahoo! Finance)
CHICAGO----As a termination of the completed merger between Merck & Co., Inc. and Schering-Plough Corp. yesterday, Fitch Ratings has downgraded Merck's Issuer Default Rating to 'A+' from 'AA-' and upgraded Schering-Plough's IDR to 'A+' from 'BBB+'.
Sunday, November 15, 2009
Endo Pharmaceuticals reaches patent litigation settlement with LecTec (News-Medical-Net)
Endo Pharmaceuticals announced today that it has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510.
Sunday, November 08, 2009
Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; Outlook Stable (Business Wire via Yahoo! Finance)
CHICAGO----As a result of the completed merger between Merck & Co., Inc. and Schering-Plough Corp. yesterday, Fitch Ratings has downgraded Merck's Issuer Default Rating to 'A+' from 'AA-' and upgraded Schering-Plough's IDR to 'A+' from 'BBB+'.
Sunday, November 01, 2009
Local woman feels effects of Pfizer lawsuit (Siskiyou Daily News)
When Amber Schriver walked into the doctorâs office a year and a half ago complaining of back pain, she never imagined that just a few weeks later she would be experiencing loss of sight.
